Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.28 USD | -0.13% | -4.87% | -7.43% |
05-22 | Kalvista Pharmaceuticals Insider Sold Shares Worth $258,337, According to a Recent SEC Filing | MT |
04-22 | Kalvista Pharmaceuticals, Inc. Appoints William C. Fairey to the Board of Directors | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.43% | 476M | |
-2.00% | 90.27B | |
-1.18% | 40.12B | |
-15.81% | 31.75B | |
+62.86% | 26.6B | |
-21.62% | 14.41B | |
-8.71% | 12.92B | |
-15.05% | 11.44B | |
-45.69% | 11.3B | |
+4.94% | 8.87B |
- Stock Market
- Equities
- KALV Stock
- News KalVista Pharmaceuticals, Inc.
- Transcript : KalVista Pharmaceuticals, Inc. Presents at Jefferies 2019 London Healthcare Conference, Nov-21-2019 08